Govt panel recommends market authorisation for Covovax jab as heterologous booster dose

Prakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs Controller General of India (DCGI) for approval of Covovax heterologous booster dose for those aged 18 years and above in view of escalating COVID-19 pandemic situation in some countries, official sources said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oTmvxqU
via IFTTT